LL37
LL-37 is a 37-amino-acid peptide produced from the human cathelicidin precursor hCAP18. It is studied as part of innate immune defense, with laboratory work examining antimicrobial activity and the recruitment of immune cells. Its interactions with membranes and cellular signaling pathways also make it relevant to research on inflammation and tissue responses.
Primary research focus: Performance & Recovery. This description is not a medical indication.
Presentations & pricing
5mg · $220
Select a presentation above to update the vial, label and inquiry. The team confirms availability and next steps.
Research information only; this page does not provide dosing, prescribing or treatment instructions. Verify regulatory status and documentation for the applicable product and lot.

